Editorial
Welcome to the first homepage edition of i2P for 2012.
In many ways it has been a slow start to the New Year because of having to deal with the “leftovers” from 2011.
One of those items for i2P was that a third-party provider to the site did not advise of a code change to the security section in our subscribe panel, creating a range of frustrated subscribers not able to get on board.
We apologise to all those potential subscribers who were unable to register with us in the second half of 2011, but if you try once more you should have no problem.
Columns
Rollo Manning: Pharma-Goss
Linda Bryant: Inside NZ
Loretta Marron BSc: Health Watch
Barry Urquhart: Marketing Focus
Mark Neuenschwander: I`ve been thinking about...Recent Comments
Past Editions
Volume 1 Number 1
Volume 1 Number 2
Volume 1 Number 3
Volume 1 Number 4
Volume 1 Number 5
Volume 1 Number 6
Volume 1 Number 7
Volume 2 Number 1
Volume 2 Number 2
Volume 2 Number 3
Volume 2 Number 4
Volume 2 Number 5
Volume 2 Number 6
Volume 2 Number 7
Volume 2 Number 8
Volume 2 Number 9
Volume 2 Number 10
Volume 2 Number 11
Volume 3 Number 1
Volume 3 Number 2
Volume 3 Number 3
Volume 3 Number 4
Volume 3 Number 5
Volume 3 Number 6
Volume 3 Number 7
Volume 3 Number 8
Volume 3 Number 9
Volume 3 Number 10
Volume 3 Number 11
Volume 2012 Number 1
Health Politics
Neil Johnston: Friends of Science in Medicine
Peter Sayers: Confessions of a Frustrated Pharmacist
James Ellerson: $75.5 million in 5CPA lying idle. Why is it so?EPublications
Research breakthrough on the question of life expectancy
Printer-friendly version
Send to friend
PDF version | Staff Writer |
Editing and Researching news and stories about global and local Pharmacy Issues | |
Why do we grow old and what can we do to stop it? This is the question asked by many, but it appears that we are now closer to an answer thanks to new research published by Monash University researcher Dr Damian Dowling.
According to the research published in the August edition of the prestigious journal, The American Naturalist, a small set of genes in mitochondria (a membrane-enclosed organelle found in most eukaryotic cells), passed only from mothers to offspring, plays a more dynamic role in predicting life expectancies than ever previously anticipated.
The research discovered that particular mitochondrial haplotypes were linked to the life expectancies of females in the beetle species Callosobruchus maculatus.
"What we found in these beetles that some combinations of mitochondrial and nuclear genomes confer long life in virgin females, but these are not the same combinations that result in long life in females that mate once, or in females that mate many times," Dr Dowling said.
"Clearly, the genetic determinants underlying life expectancies are complex.
"As we unravel this complexity, we draw closer to the day in which we might use the genetic information encoded in the mitochondria to assist in the development of therapies that slow the onset of ageing in humans," Dr Dowling said.
In animals, most of the genetic material that controls bodily functions is found inside the cell nucleus. This is the nuclear genome - it is passed on from generation to generation through both mothers and fathers, and it encodes somewhere between 14 thousand and 40 thousand proteins.
However, a separate genome exists that is found only within the energy-producing factories of our cells - the mitochondria. To put things in perspective, the mitochondrial genome is tiny, encoding just 13 proteins. Despite being so small, it can pack a punch when it comes to its ability to affect a range of fundamental biological processes.
Dr Dowling, a research fellow at Monash University's School of Biological Sciences led the research together with Goran Arnqvist of Uppsala University Sweden and their student, Tejashwari Meerupati, made the discovery.
"Our findings are part of a much broader research agenda in which we are elucidating the ways in which mitochondrial genomes have shaped our evolutionary past and present. What we are finding is that natural variation in this diminutive genome results in a huge range of effects on metabolism, mating behaviour and reproductive biology, including male fertility," Dr Dowling said.
"At the outset of our research program, we suspected that the evolutionary significance of the mitochondria had probably been underestimated by scientists that have come before us, but even we have been continually surprised by the magnitude and ubiquity of the effects that we have uncovered.
"We suspect that this genome still harbours many more secrets awaiting discovery," Dr Dowling said.
Return to homeResearch Reports
Dr Andrew Byrne & Associates: Tranquillizer use rife amongst OTP subjects world-wide, most legally prescribedPractice Development
Neil Retallick: Are the discounters impacting community pharmacy beyond margin erosion? | open full screen
Kay Dunkley - BPharm, Grad Dip Hosp Pharm, Grad Dip Health Admin, MPS, MSHPA: Support services for pharmacists and doctors in the United Kingdom – Part 3 Royal Medical Benevolent Fund | open full screen
Staff Writer: Catch the early wave in 2012 and secure your valuable CPD Credits at the Guild Pharmacy Academy – NSW Convention | open full screen
Information Technology
Dr David More: Australian Health Information Technology LinksIndigenous Health
Preventive Medicine
Gerald Quigley: It’s Time!If any difficulty is found in subscribing, please use the "Contact Us" panel found in the navigation bar with the message "subscribe" and your email address.
Post new comment